3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neuroendocrine Tumors
1
Myeloproliferative Disorders
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Interventions
fludarabine phosphate
31
Peripheral Blood Stem Cell Transplantation
26
Cyclophosphamide
25
Mycophenolic Acid
24
Whole-Body Irradiation
23
Busulfan
21
Tacrolimus
19
Cyclosporine
19
Antilymphocyte Serum
14
Methotrexate
13
Imatinib Mesylate
12
Cord Blood Stem Cell Transplantation
11
Melphalan
10
Dasatinib
10
Cyclosporins
8
nilotinib
7
Methylprednisolone
7
Etoposide
7
Radiotherapy
6
Filgrastim
6
Alemtuzumab
6
Sirolimus
5
thymoglobulin
4
sargramostim
4
bosutinib
4
Granulocyte Colony-Stimulating Factor
4
Cytarabine
4
fludarabine
3
Thiotepa
3
Rituximab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Chronic-Phase
×
entinostat
×
Clear all
No trials found.